Barr Pharmaceuticals
| Industry | Pharmaceutical industry |
|---|---|
| Founded | 1970 |
| Defunct | December 23, 2008 |
| Fate | Acquired by Teva Pharmaceutical Industries |
| Successor | Teva Active Pharmaceutical Ingredients |
| Headquarters | , |
Area served | Worldwide |
Key people | Bruce L. Downey, Chairman & CEO William T. McKee, CFO |
| Products | Generic drugs |
Number of employees | 8,900 (2007) |
| Footnotes / references | |
Barr Pharmaceuticals was an American specialty and generic drug manufacturer with operations in 30 countries. Approximately 75% of the company's revenues came from the sale of generic drugs, including 18% of sales which were from the sale of oral contraceptive pills.
It was acquired by Teva Pharmaceutical Industries in 2008 for an estimated $7.46 billion ($10.9 billion in 2024).